Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...

Key market opportunities in the CDMO for formulations sector include increasing demand for custom peptide synthesis, ...

AstraZeneca today officially opened their new Active Pharmaceutical Ingredient (API) manufacturing facility in Dublin. This new facility demonstrates how advanced automation, AI, and innovative new ...

Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...

According to the latest market analysis by Future Market Insights, the global small molecule API market is entering a phase of stable a ...

CDMO Olon is continuing its expansion binge with a deal to buy an API plant in India that supplies ingredients to Novartis. The Italian generic drug and API maker said Tuesday that it is buying an API ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.

Pakistan’s pharmaceutical manufacturing industry is one of the country’s largest and fastest growing industries. It includes more than 650 manufacturers and accounts for approximately Rs. 748 billion ...

The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031. Demand for biologics, biosimilars, and other biopharmaceuticals is growing at a ...